Prolonged glucocorticoid treatment is associated with improved ARDS outcomes: analysis of individual patients' data from four randomized trials and trial-level meta-analysis of the updated literature (Q35823842)

From Wikidata

Jump to navigation Jump to search

scientific article published on 27 October 2015

Language	Label	Description	Also known as
English	Prolonged glucocorticoid treatment is associated with improved ARDS outcomes: analysis of individual patients' data from four randomized trials and trial-level meta-analysis of the updated literature	scientific article published on 27 October 2015

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

0 references

Prolonged glucocorticoid treatment is associated with improved ARDS outcomes: analysis of individual patients' data from four randomized trials and trial-level meta-analysis of the updated literature (English)

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

acute respiratory distress syndrome

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

4

object named as

Paul E Marik

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

Reed Alexander Siemieniuk

5

object named as

Reed A C Siemieniuk

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

author name string

G Umberto Meduri

1

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

Lisa Bridges

2

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

Mei-Chiung Shih

3

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

Mehmet Kocak

6

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

27 October 2015

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

Intensive Care Medicine

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

42

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

5

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

829-840

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

Activation and regulation of systemic inflammation in ARDS: rationale for prolonged glucocorticoid therapy

1 reference

https://api.crossref.org/works/10.1007%2FS00134-015-4095-4

21 January 2018

Understanding ARDS-associated fibroproliferation

1 reference

https://api.crossref.org/works/10.1007%2FS00134-015-4095-4

21 January 2018

Corticosteroid therapy for acute lung injury, acute respiratory distress syndrome, and severe pneumonia: a meta-analysis of randomized controlled trials

1 reference

https://api.crossref.org/works/10.1007%2FS00134-015-4095-4

21 January 2018

Prospective meta-analysis using individual patient data in intensive care medicine

1 reference

https://api.crossref.org/works/10.1007%2FS00134-015-4095-4

21 January 2018

Methylprednisolone infusion in early severe ARDS: results of a randomized controlled trial.

1 reference

https://api.crossref.org/works/10.1007%2FS00134-015-4095-4

21 January 2018

Effect of prolonged methylprednisolone therapy in unresolving acute respiratory distress syndrome: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1007%2FS00134-015-4095-4

21 January 2018

Efficacy and safety of corticosteroids for persistent acute respiratory distress syndrome

1 reference

https://api.crossref.org/works/10.1007%2FS00134-015-4095-4

21 January 2018

Steroid treatment in ARDS: a critical appraisal of the ARDS network trial and the recent literature

1 reference

https://api.crossref.org/works/10.1007%2FS00134-015-4095-4

21 January 2018

Hydrocortisone infusion for severe community-acquired pneumonia: a preliminary randomized study

1 reference

https://api.crossref.org/works/10.1007%2FS00134-015-4095-4

21 January 2018

Effect of low doses of corticosteroids in septic shock patients with or without early acute respiratory distress syndrome

1 reference

https://api.crossref.org/works/10.1007%2FS00134-015-4095-4

21 January 2018

Use of the SOFA score to assess the incidence of organ dysfunction/failure in intensive care units: results of a multicenter, prospective study. Working group on "sepsis-related problems" of the European Society of Intensive Care Medicine.

1 reference

https://api.crossref.org/works/10.1007%2FS00134-015-4095-4

21 January 2018

GRADE: an emerging consensus on rating quality of evidence and strength of recommendations

1 reference

https://api.crossref.org/works/10.1007%2FS00134-015-4095-4

21 January 2018

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement

1 reference

https://api.crossref.org/works/10.1007%2FS00134-015-4095-4

21 January 2018

Use of corticosteroids in acute lung injury and acute respiratory distress syndrome: a systematic review and meta-analysis.

1 reference

https://api.crossref.org/works/10.1007%2FS00134-015-4095-4

21 January 2018

Stopping randomized trials early for benefit and estimation of treatment effects: systematic review and meta-regression analysis

1 reference

https://api.crossref.org/works/10.1007%2FS00134-015-4095-4

21 January 2018

Understanding the inflammatory cytokine response in pneumonia and sepsis: results of the Genetic and Inflammatory Markers of Sepsis (GenIMS) Study

1 reference

https://api.crossref.org/works/10.1007%2FS00134-015-4095-4

21 January 2018

Inflammatory cytokines in the BAL of patients with ARDS. Persistent elevation over time predicts poor outcome

1 reference

https://api.crossref.org/works/10.1007%2FS00134-015-4095-4

21 January 2018

Plasma and BAL Cytokine Response to Corticosteroid Rescue Treatment in Late ARDS

1 reference

https://api.crossref.org/works/10.1007%2FS00134-015-4095-4

21 January 2018

Corticosteroid treatment in severe community-acquired pneumonia: duration of treatment affects control of systemic inflammation and clinical improvement.

1 reference

https://api.crossref.org/works/10.1007%2FS00134-015-4095-4

21 January 2018

Steroid treatment for persistent ARDS: a word of caution

1 reference

https://api.crossref.org/works/10.1007%2FS00134-015-4095-4

21 January 2018

Recommendations for the diagnosis and management of corticosteroid insufficiency in critically ill adult patients: consensus statements from an international task force by the American College of Critical Care Medicine

1 reference

https://api.crossref.org/works/10.1007%2FS00134-015-4095-4

21 January 2018

Corticosteroid Therapy for Patients Hospitalized With Community-Acquired Pneumonia

1 reference

https://api.crossref.org/works/10.1007%2FS00134-015-4095-4

21 January 2018

Methylprednisolone achieves greater concentrations in the lung than prednisolone. A pharmacokinetic analysis

1 reference

https://api.crossref.org/works/10.1007%2FS00134-015-4095-4

21 January 2018

Corticosteroids in acute respiratory failure

1 reference

https://api.crossref.org/works/10.1007%2FS00134-015-4095-4

21 January 2018

Neuromuscular blockers in early acute respiratory distress syndrome

1 reference

https://api.crossref.org/works/10.1007%2FS00134-015-4095-4

21 January 2018

Successful therapy of severe pneumonia-associated ARDS after pneumonectomy with ECMO and steroids

1 reference

https://api.crossref.org/works/10.1007%2FS00134-015-4095-4

21 January 2018

Nuclear factor-kappaB- and glucocorticoid receptor alpha- mediated mechanisms in the regulation of systemic and pulmonary inflammation during sepsis and acute respiratory distress syndrome. Evidence for inflammation-induced target tissue resistance

1 reference

https://pubmed.ncbi.nlm.nih.gov/26508525

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Acute respiratory distress syndrome: the Berlin Definition

1 reference

https://pubmed.ncbi.nlm.nih.gov/26508525

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Procollagen types I and III aminoterminal propeptide levels during acute respiratory distress syndrome and in response to methylprednisolone treatment

1 reference

https://pubmed.ncbi.nlm.nih.gov/26508525

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prolonged methylprednisolone treatment suppresses systemic inflammation in patients with unresolving acute respiratory distress syndrome: evidence for inadequate endogenous glucocorticoid secretion and inflammation-induced immune cell resistance to

1 reference

https://pubmed.ncbi.nlm.nih.gov/26508525

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[The effect of stress dose glucocorticoid on patients with acute respiratory distress syndrome combined with critical illness-related corticosteroid insufficiency]

1 reference

https://pubmed.ncbi.nlm.nih.gov/26508525

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Suppression and recovery of adrenal response after short-term, high-dose glucocorticoid treatment

1 reference

https://pubmed.ncbi.nlm.nih.gov/26508525

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Persistent elevation of inflammatory cytokines predicts a poor outcome in ARDS. Plasma IL-1 beta and IL-6 levels are consistent and efficient predictors of outcome over time

1 reference

https://pubmed.ncbi.nlm.nih.gov/26508525

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S00134-015-4095-4

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35823842&oldid=2197799993"